Other red cell antibodies may rarely cause mild extravascular hemolysis but not intravascular ... physician and the transfusion department/laboratory must be notified immediately and the reactions ...

AstraZeneca (NASDAQ:AZN) has received FDA approval for its drug Voydeya, also known as danicopan, as an add-on therapy to Ultomiris or Soliris in the treatment of extravascular hemolysis in adults ...

reported in the ALPHA trial evaluating VOYDEYA as add-on to ULTOMIRIS or SOLIRIS in patients with PNH experiencing clinically significant extravascular hemolysis (EVH) and separately in the ...

“The extravascular, intrapericardial balloon implant requires no large vessel access, and the system avoids many of the current standard of care complications, such as major bleeding, hemolysis ...